The pharmaceutical industry is undergoing important structural changes. The increase in the cost of research, the appearance of non-insured medical needs and the need to tackle more global markets is leading to an important concentration of companies striving for greater size and scale. These companies must also face new challenges due to increased regulations, with stricter requirements for the approval of specifications, the growth of generic products that compete with patents and greater restrictions and regulations on reference prices. On the other hand, consumers are taking more control of their healthcare, which is fostering preventive medicine and different business models, and distributors are facing a change in distribution model and how to deal with POS’s to optimize their margins.
Executives in this segment must have a global and strategic vision of the markets and the ability to constantly readapt their business models and team profiles. The ability to lead change and encourage innovation, a strong focus on productivity, efficiency and return on investment are some of the essential characteristic that are needed to tackle this sector’s complex environment.
At Amrop Seeliger y Conde, we start with an in-depth knowledge of our clients and their strategies, objectives and culture, and based on these we work together to find the best fit for the executive’s technical and cultural skills and ensure the success of their management.
Amrop Seeliger y Conde has carried out numerous projects with companies that manufacture and/or distribute pharmaceutical products and work in the biotech, generic medicines, medical devices, diagnostics, health and hospital services, and consumer health fields as well as with a broad spectrum of products and services.
Amrop Seeliger y Conde’s clients include prestigious Spanish and international companies that we have helped to expand internationally.
Amrop Seeliger y Conde continuously monitors the sector: